Cargando…

Targeting age-related inflammation in myelodysplastic syndromes

Detalles Bibliográficos
Autores principales:	Mei, Yang, Ji, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226038/ https://www.ncbi.nlm.nih.gov/pubmed/30459930 http://dx.doi.org/10.18632/oncotarget.26266

Ejemplares similares

Risk stratification in therapy-related myelodysplastic syndromes
por: Zeidan, Amer M.
Publicado: (2017)

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia
por: Weeks, Lachelle D., et al.
Publicado: (2022)

Targeting R-loop-associated ATR response in myelodysplastic syndrome
por: Nguyen, Hai Dang, et al.
Publicado: (2019)

Myelodysplastic Syndrome: Riding the Crest of the Wave
por: Ramos, Fernando
Publicado: (2022)

Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome
por: Yabe, Hiroki
Publicado: (2018)

Knowledge of Secondary Pulmonary Alveolar Proteinosis Complicated with Myelodysplastic Syndrome
por: Ishii, Haruyuki
Publicado: (2019)

Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome
por: Baliakas, Panagiotis, et al.
Publicado: (2021)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
por: Blum, Sabine, et al.
Publicado: (2021)

Metchnikoff’s legacy: the dysplastic nature of innate immunity in myelodysplastic syndromes
por: Greenberg, Peter L.
Publicado: (2021)

Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes
por: Vallelonga, Veronica, et al.
Publicado: (2023)

Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes
por: Zhao, Baobing, et al.
Publicado: (2019)

Immune dysregulation and potential targeted therapy in myelodysplastic syndrome
por: Zhang, Xiaoying, et al.
Publicado: (2023)

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
por: Lee, Paul, et al.
Publicado: (2021)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome
por: Man, Na, et al.
Publicado: (2018)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes
por: van de Loosdrecht, Arjan A., et al.
Publicado: (2022)

From cell surface to nucleus: CCRL2 regulates response to hypomethylating agents in myelodysplastic syndromes
por: Saygin, Caner
Publicado: (2023)

Infections in Myelodysplastic Syndrome in Relation to Stage and Therapy
por: Leone, Giuseppe, et al.
Publicado: (2018)

The microenvironment in myelodysplastic syndromes: From concept to therapeutic target
por: Raaijmakers, Marc H.G.P.
Publicado: (2018)

Myelodysplastic syndromes and overlap syndromes
por: Chang, Yoon Hwan
Publicado: (2021)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Myelodysplastic Syndromes and Metabolism
por: Balaian, Ekaterina, et al.
Publicado: (2021)

Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021)

Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome
por: Merrill, Andrea L., et al.
Publicado: (2011)

MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
por: Bayley, Rachel, et al.
Publicado: (2018)

Spotlight on decitabine for myelodysplastic syndromes in Chinese patients
por: Jing, Yu, et al.
Publicado: (2015)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosis
por: Hong, Minghua, et al.
Publicado: (2021)

Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
por: Zhou, Jing-dong, et al.
Publicado: (2020)

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
por: Gill, Harinder, et al.
Publicado: (2016)

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
por: Woll, Petter S., et al.
Publicado: (2022)

Bioinformatics analysis of high frequency mutations in myelodysplastic syndrome-related patients
por: Wu, Kun, et al.
Publicado: (2021)

Techniques for detecting chromosomal aberrations in myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

Summary of animal models of myelodysplastic syndrome
por: Li, Weisha, et al.
Publicado: (2021)

Identify latent chromosomal aberrations relevant to myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

Decitabine in the treatment of myelodysplastic syndromes
por: Saba, Hussain I
Publicado: (2007)

Cytogenetic features in myelodysplastic syndromes
por: Haase, Detlef
Publicado: (2008)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Immune dysregulation in myelodysplastic syndrome
por: Sugimori, Chiharu, et al.
Publicado: (2010)

Comet assay in myelodysplastic syndromes
por: Teixeira Neto, Paulo Florentino, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f629h462ksl055i8q3pmeep1on